Proteasomes, essential protein complexes responsible for degrading unneeded or damaged proteins, maintain cellular homeostasis across virtually all cell types, including neurons. The ATPase subunits of the proteasome, such as PSMC5, serve pivotal roles in substrate recognition and unfolding, facilitating the targeted proteolysis that sustains neuronal health. However, mutations or dysfunctions in these components have been linked increasingly to neurodevelopmental disorders termed proteasomopathies, characterized by developmental delay, intellectual disabilities, and motor dysfunction.

The study by Küry and colleagues embarks on an in-depth investigation into how PSMC5 specifically modulates neuronal proteostasis and developmental trajectories. Employing a combination of genetic, biochemical, and neurobiological tools, the team dissected how alteration of PSMC5 expression affects proteasome function and neuronal health. Their findings convincingly demonstrate that loss of PSMC5 disrupts proteasomal activity, leading to accumulation of ubiquitinated proteins and impaired degradation pathways that are crucial in neurons.

Using advanced gene editing techniques such as CRISPR-Cas9, the researchers engineered neuronal models deficient in PSMC5. These cell systems exhibited marked abnormalities in proteasome assembly and function. Importantly, these deficiencies translated into defective neuronal differentiation and synaptic connectivity, highlighting PSMC5’s indispensable role in orchestrating the proteasome’s function during critical periods of brain development.

Furthermore, the researchers delved into the mechanistic pathways by which PSMC5 loss induces cellular stress. They found increased levels of proteotoxic stress markers and an aberrant activation of stress response pathways within neurons. This dysregulation is posited to contribute to the clinical manifestations seen in neurodevelopmental proteasomopathies, where neuronal survival and function are compromised due to proteostasis imbalance.

A striking aspect of this work is the delineation of PSMC5’s interaction network within the proteasome complex and its influence on ATP hydrolysis, which powers the mechanical unfolding and translocation of substrates into the proteolytic core. By utilizing proteomic approaches, the authors mapped protein interactions that are lost or altered in PSMC5 mutants, providing a molecular framework for how specific ATPase subunit impairments translate into broad proteasomal dysfunction.

Beyond the cellular and molecular insights, the study extends to patient-derived samples and identifies pathogenic variants in PSMC5 associated with severe neurodevelopmental phenotypes. This translational component not only establishes PSMC5 as a candidate gene for diagnosis but also opens avenues for therapeutic strategies targeting proteasomal machinery to mitigate disease progression.

The implications of these findings resonate deeply within the neuroscientific and clinical communities. By pinpointing a crucial node in the proteasomal network responsible for maintaining neuronal integrity, Küry et al. set the stage for innovative approaches in both the diagnosis and potential treatment of proteasomopathies. Therapeutic modulation of proteasome activity or enhancing compensatory degradation pathways might emerge as viable strategies in managing such currently untreatable disorders.

Moreover, this research sheds light on the broader significance of proteostasis in brain health. Neurons, due to their longevity and complex morphology, are exquisitely sensitive to disturbances in protein turnover. The precise tuning of proteasome function, as orchestrated by components such as PSMC5, emerges from this work as a linchpin in safeguarding neurodevelopment and sustaining cognitive function.

The study also invites further inquiry into the selective vulnerabilities of neuronal populations to proteasomal deficits. Why some neurons are more susceptible to PSMC5 disruption than others remains an intriguing question. Future research can build upon these insights to unravel cell-type-specific mechanisms and identify biomarkers predictive of disease severity and progression.

In summary, this seminal work not only advances our molecular understanding of PSMC5 within the proteasomal system but also forges critical links between proteasomal impairment and neurodevelopmental disease. The meticulous experimentation and cross-disciplinary approach exemplify how unraveling molecular pathomechanisms can enlighten complex neurological disorders and inspire novel therapeutic directions.

As the field moves forward, the challenge will be to translate these discoveries into clinical applications that can improve patient outcomes. The potential for developing small molecules or gene-based therapies that rectify proteasome dysfunction holds promise, catalyzed by foundational studies such as this. By decoding the neuronal proteasome’s inner workings, scientists inch closer to interventions that may one day alleviate the burden of proteasomopathies.

This landmark study reaffirms the centrality of proteostasis in neurological health and disease and spotlights PSMC5 as a key molecular player deserving of further exploration. Its contribution to the literature not only enriches our understanding of neurodevelopmental biology but also inspires hope for future breakthroughs in the treatment of these devastating disorders.

Subject of Research:
The neuronal function of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies.

Article Title:
Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies.

Article References:
Küry, S., Stanton, J.E., van Woerden, G.M. et al. Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies. Nat Commun 16, 10545 (2025). https://doi.org/10.1038/s41467-025-65556-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-025-65556-8

In a groundbreaking study spearheaded by Dr. Kazuhide Asakawa at the National Institute of Genetics in Japan, researchers have harnessed the power of single-cell–resolution imaging within transparent zebrafish models to probe the cellular mechanisms behind motor neuron vulnerability in ALS. This innovative approach allowed them to observe, in unprecedented detail, the physiological status and stress responses of individual spinal motor neurons in a living organism, linking structural properties with cellular dynamics.

The team’s observations reveal that large spinal motor neurons, tasked with generating powerful body movements and notably susceptible in ALS pathology, endure an inherent and continuous burden related to protein and organelle degradation. These neurons consistently exhibit elevated basal activity in three critical cellular pathways: autophagy, proteasome-mediated degradation, and the unfolded protein response. Together, these mechanisms constitute the cell’s principal modalities for maintaining protein and organelle quality control, suggesting that large motor neurons are persistently engaged in managing extensive proteostatic stress.

Autophagy involves the sequestration and lysosomal breakdown of damaged organelles and misfolded proteins, while proteasome activity facilitates the degradation of ubiquitinated proteins that could otherwise aggregate and impair cellular function. The unfolded protein response is triggered by endoplasmic reticulum (ER) stress, initiating a molecular reaction aimed at restoring proper protein folding. Elevated baseline activity in these systems points to a metabolic state where motor neurons operate near their degradation capacity limits under normal physiological conditions.

Intertwined with this intrinsic stress profile is the role of TDP-43, a DNA/RNA-binding protein that has emerged as a pivotal player in ALS pathology. Functional impairment or loss of TDP-43 protein dramatically exacerbates the degradation burden. The researchers found that early-phase acceleration of protein and organelle turnover — induced by TDP-43 dysfunction — initially supports axonal growth and neuronal plasticity, indicating a compensatory cellular response aimed at maintaining motor neuron function under stress.

However, this adaptive response is a double-edged sword. Over time, persistent hyperactivation of degradation pathways overwhelms cellular homeostasis, accelerating pathological processes that culminate in selective neuronal degeneration. This exhaustion model sheds light on why considerable proteostatic strain precedes motor neuron loss, aligning with clinical observations of progressive functional decline in ALS patients.

Dr. Asakawa explains, “The sheer size and elevated metabolic demand of these large motor neurons impose a relentless degradation workload. Our findings help explain why these cells are predisposed to early degeneration in ALS, highlighting the degradation burden as a potential therapeutic target.” This insight opens the door to strategies aiming to mitigate proteostatic stress — for instance, by modulating autophagy or proteasomal activity — as a promising avenue for future ALS interventions.

This work not only clarifies the cellular basis for ALS motor neuron selectivity but also enriches the broader landscape of neurodegenerative disease research, in which protein quality control dysfunction is a recurring theme. By pinpointing the intrinsic vulnerabilities of neuron subtypes based on their biological and morphological characteristics, the study offers a refined framework for understanding and potentially delaying neurodegeneration.

Further, the use of transparent zebrafish as a vertebrate model for real-time, single-cell analysis underscores the transformative potential of advanced imaging techniques in neuroscience. The capacity to visualize protein degradation dynamics within living neurons may catalyze discoveries across multiple neurodegenerative disorders characterized by proteostasis imbalance.

The findings prompt a reconsideration of how cellular stress responses are managed within large neurons and their correlation with disease onset and progression. Increased baseline degradation activity suggests a perpetual cellular attempt to counteract accumulating proteotoxic stress but also reveals the thin margin between adaptation and failure. Understanding where this threshold lies in motor neurons could be critical to developing interventions that preserve neuron integrity before irreversible damage ensues.

This study enriches ALS research by linking the cell biology of motor neurons to their unique pathological trajectory. The interplay of cell size, metabolic demands, and stress-response pathways outlines a mechanistic narrative explaining why these neurons succumb preferentially. Moreover, the identification of TDP-43’s role in magnifying intrinsic degradation stress consolidates its status as a central molecular culprit, encouraging further research into ways to protect or restore its function.

By elucidating these complex cellular relationships, Dr. Asakawa and colleagues provide a compelling explanation for long-standing clinical observations and experimental findings. Their work offers a beacon of hope for future therapeutic development, suggesting that reducing the proteostatic load on vulnerable neurons might slow, halt, or even reverse the relentless march of ALS.

In summary, the discovery that large spinal motor neurons naturally operate under heightened degradation demands—and that the loss of TDP-43 exacerbates this stress culminating in cell death—represents a pivotal advancement in ALS pathophysiology. This study not only solves key pieces of the ALS puzzle but also sets a foundation for innovative neuroprotective therapies that target intrinsic cellular liabilities before disease manifestation becomes irreversible.

Subject of Research: Cellular mechanisms underlying selective motor neuron vulnerability in amyotrophic lateral sclerosis (ALS) through proteostasis and degradation burden analysis.

Article Title: [Not explicitly provided in source content]

News Publication Date: [Not explicitly provided in source content]

Web References:

• National Institute of Genetics: https://www.nig.ac.jp/nig/
• Research Organization of Information and Systems (ROIS): https://www.rois.ac.jp/en/index.html
• DOI link to original paper: http://dx.doi.org/10.1038/s41467-025-65097-0

Image Credits: Kazuhide Asakawa, National Institute of Genetics

Keywords: amyotrophic lateral sclerosis, ALS, motor neurons, proteostasis, protein degradation, autophagy, proteasome, unfolded protein response, TDP-43, neurodegeneration, zebrafish model, neurobiology